Anti‐obesity effects of resveratrol: from in vivo to in vitro study
Keng-Yang Lin(Chang Gung University), Li‐Man Hung(Chang Gung University of Science and Technology), Kang‐Yu Peng(The University of Sydney)
Cited by 2
Related Papers
Mitochondrial dysfunction-related lipid changes occur in nonalcoholic fatty liver disease progression
|Journal of Lipid Research|2018|226
Resveratrol retards progression of diabetic nephropathy through modulations of oxidative stress, proinflammatory cytokines, and AMP-activated protein kinase
|Journal of Biomedical Science|2011|124
Resveratrol exerts anti-obesity effects in high-fat diet obese mice and displays differential dosage effects on cytotoxicity, differentiation, and lipolysis in 3T3-L1 cells
|Endocrine Journal|2015|101
Correlating Digestion-Driven Self-Assembly in Milk and Infant Formulas with Changes in Lipid Composition
|ACS Applied Bio Materials|2020|36